Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.
Filipović A, Lombardo Y, Faronato M, Abrahams J, Aboagye E, Nguyen QD, d'Aqua BB, Ridley A, Green A, Rahka E, Ellis I, Recchi C, Przulj N, Sarajlić A, Alattia JR, Fraering P, Deonarain M, Coombes RC.
Filipović A, et al. Among authors: recchi c.
Breast Cancer Res Treat. 2014 Nov;148(2):455-62. doi: 10.1007/s10549-014-3119-z. Epub 2014 Sep 24.
Breast Cancer Res Treat. 2014.
PMID: 25248409
Free PMC article.